Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-67,500
Closed -$1.04M 375
2023
Q3
$1.04M Buy
+67,500
New +$1.13M 0.04% 235
2023
Q2
Sell
-27,100
Closed -$413K 407
2023
Q1
$413K Sell
27,100
-40,400
-60% -$527K 0.02% 277
2022
Q4
$859K Buy
+67,500
New +$607K 0.04% 233

Other funds holding ETNB

J. Goldman & Co's ETNB Position: Q3 2025 in Review

J. Goldman & Co sold out of 89bio (ETNB) in Q3 2025, closing a stake of 96,339 shares — an estimated $946K sold.

J. Goldman & Co first reported a position in ETNB in Q4 2022 and held it in 4 quarters. The position peaked at $1.04M in Q1 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • J. Goldman & Co reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • J. Goldman & Co sold 96,339 89bio shares in Q3 2025, an estimated $946K.
  • J. Goldman & Co first reported a position in 89bio in Q4 2022 and held it in 4 quarters.
  • J. Goldman & Co's 89bio position peaked at $1.04M in Q1 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.